A

Andlauer Healthcare Group Inc
TSX:AND

Watchlist Manager
Andlauer Healthcare Group Inc
TSX:AND
Watchlist
Price: 54.97 CAD 0.02% Market Closed
Market Cap: 2.2B CAD

Andlauer Healthcare Group Inc
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Andlauer Healthcare Group Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
Andlauer Healthcare Group Inc
TSX:AND
Net Issuance of Debt
-CA$43m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Net Issuance of Debt
CA$49m
CAGR 3-Years
42%
CAGR 5-Years
42%
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Net Issuance of Debt
-CA$26.8m
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Net Issuance of Debt
CA$307.5k
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
-21%
NeuPath Health Inc
XTSX:NPTH
Net Issuance of Debt
-CA$1.9m
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Net Issuance of Debt
-CA$394k
CAGR 3-Years
47%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Andlauer Healthcare Group Inc
Glance View

Market Cap
2.2B CAD
Industry
Health Care

Andlauer Healthcare Group Inc. operates within the specialized realm of healthcare logistics and transportation, commanding its niche with precision and efficiency. Founded in 1991, the company has carved a distinct position in the Canadian market, known for its tailored solutions that meet the complex demands of the healthcare sector. From pharmaceutical companies to biotechnology firms, Andlauer serves clients who rely on the timely and secure transportation of sensitive healthcare products. With a network of temperature-controlled transportation and warehousing facilities, the company ensures that critical shipments maintain their integrity throughout their journey. This specialization not only supports the compliance needs of their customers but also positions Andlauer as an indispensable partner in the healthcare supply chain. Revenue generation for Andlauer primarily stems from its comprehensive suite of logistics and transportation services, which are tailored specifically for the nuances of the healthcare industry. By offering end-to-end solutions that encompass distribution, specialized transport, and dedicated warehousing, the company captures diverse streams of income within this highly regulated sector. Additional value comes from their technology-driven approach, harnessing data and analytics to optimize routing and improve supply chain visibility. Through strategic acquisitions and partnerships, Andlauer continues to expand its footprint, enhancing service capabilities and geographical reach. This calculated growth strategy not only solidifies its market leadership but also fortifies its financial performance in a rapidly evolving industry landscape.

AND Intrinsic Value
40.35 CAD
Overvaluation 27%
Intrinsic Value
Price
A

See Also

What is Andlauer Healthcare Group Inc's Net Issuance of Debt?
Net Issuance of Debt
-43m CAD

Based on the financial report for Jun 30, 2025, Andlauer Healthcare Group Inc's Net Issuance of Debt amounts to -43m CAD.

What is Andlauer Healthcare Group Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
25%

Over the last year, the Net Issuance of Debt growth was -211%. The average annual Net Issuance of Debt growth rates for Andlauer Healthcare Group Inc have been 10% over the past three years , 25% over the past five years .

Back to Top